Litcius/Paper detail

IL-6 in pulmonary hypertension: why novel is not always best

Mark Toshner, Alexander Rothman

2020European Respiratory Journal29 citationsDOIOpen Access PDF

Abstract

<b>Previous preclinical data on IL-6 validated in a large multicentre biobank study. IL-6 is associated with mortality and levels vary related to underlying aetiology. This has relevance to experimental medicine attempts to translate immunomodulatory therapy.</b>https://bit.ly/2WTFUMQ

Topics & Concepts

MedicineBiobankPulmonary hypertensionEtiologyRelevance (law)Intensive care medicineClinical significanceInternal medicineBioinformaticsPolitical scienceLawBiologyPulmonary Hypertension Research and TreatmentsLiver Disease and TransplantationChronic Obstructive Pulmonary Disease (COPD) Research